Perioperative Pain Management in Opioid-Tolerant Patients
The Perioperative Pain Management in Opioid-Tolerant Patients course was presented at ACS Clinical Congress 2017 and was part of a larger panel session focused on surgical perioperative strategies to reduce opioid consumption while maintaining safe and effective pain control.
James B. Ray, PharmD, CPE, shares best practices for managing surgical pain in opioid-tolerant patients, specifically those who may be taking buprenorphine, methadone, or naltrexone. Additionally, he includes opioid-related adverse drug events that must be watched for while patients are hospitalized, centering specifically on avoiding respiratory depression and sleep-disordered breathing conditions, which can quickly become fatal.
Additional courses in this series will focus on an introduction to the national opioid epidemic as well as pharmacologic considerations when selecting and utilizing multimodal pain control therapies for opioid-naive patients.
The online course, Perioperative Pain Management in Opioid-Tolerant Patients offered by the American College of Surgeons Division of Education is intended for use only by the course participant. Thank you in advance for your participation.
- Health care professionals with patients who are opioid-dependent
- Identify perioperative strategies for managing acute postsurgical pain in opioid-tolerant patients
- Recognize the most common opioid-related, adverse drug events (ORADEs) in perioperative management.
- Additional resources
- Course evaluation
If you have any questions about this course, please contact firstname.lastname@example.org.
If you have any technical questions, contact email@example.com.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest (see below for definitions).
The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Faculty and Disclosure
James B. Ray, PharmD, CPE
University of Iowa, College of Pharmacy
Clinical Associate Professor, Department of Pharmacy Practice and Science
Otterbeck Professor in Hospice and Palliative Care
Disclosures: Receives consulting fees from Alchemy Consulting
- 0.75 AMA PRA Category 1 Credit™
- 0.75 Certificate of Completion
- 0.75 Self Assessment Credit